Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function

Metformin therapy in patients with chronic kidney disease

(2012) J. K. Duong et al.   DIABETES OBESITY & METABOLISM

Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus

(2012) Christophe Bardin et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency Situations

(2011) Jean-Daniel Lalau et al.   CLINICAL DRUG INVESTIGATION

Clinical Pharmacokinetics of Metformin

(2011) Garry G. Graham et al.   CLINICAL PHARMACOKINETICS

Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?

(2011) Helen J. Nye et al.   NEPHRON CLINICAL PRACTICE

The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c

(2011) Mette M.H. Christensen et al.   Pharmacogenetics and Genomics

Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal Function: Clinical recommendations

(2010) A. Frid et al.   DIABETES CARE

The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin

(2009) M V Tzvetkov et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver

(2009) Anne T. Nies et al.   HEPATOLOGY

Lean body mass normalizes the effect of obesity on renal function

(2008) Sarayut Janmahasatian et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infection

(2008) Juliana F. Roos et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Population Exposure-Response Modeling of Metformin in Patients With Type 2 Diabetes Mellitus

(2008) Ying Hong et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Population modelling of the effect of inogatran, at thrombin inhibitor, on ex vivo coagulation time (APTT) in healthy subjects and patients with coronary artery disease

(2003) Marie Cullberg et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY